Study guide
15.1 Patient Care, Education, and Consent
Certified Nuclear Medicine Technologist CNMT
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current CNMT Exam Facts 1.2 How to Use This Guide
2 Radiation Physics Fundamentals
2.1 Radioactive Materials, Isotopes, and Decay Modes 2.2 Decay Calculations and Counting Statistics 2.3 Interactions of Radiation with Matter 2.4 Radiation Detector Types and Principles
3 Biological Effects & ALARA
3.1 Biological Effects of Radiation Exposure 3.2 ALARA and Protection Calculations 3.3 Dose Limits, Surveys, and Personal Monitoring
4 NRC & Regulatory Compliance
4.1 NRC Areas, Spills, Waste, and Records 4.2 Written Directives and DOT Shipping 4.3 EPA, OSHA, HIPAA, FDA, and USP Standards 4.4 Radioactive Waste Disposal and Regulatory Records
5 Generators & Kit Preparation
5.1 Radionuclide Generators and Quality Control 5.2 Radiopharmaceutical Kit Preparation 5.3 Radiopharmaceutical Quality Control
6 Tc-99m Diagnostic Agents
6.1 Tc-99m Cardiac Imaging Agents 6.2 Tc-99m Bone, Renal, and GU Agents 6.3 Tc-99m GI and Hepatobiliary Agents 6.4 Tc-99m CNS, Infection, and Labeled Cells
7 Non-Tc Diagnostic & PET Agents
7.1 Iodine and Indium Diagnostic Agents 7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents 7.3 PET Radiopharmaceuticals 7.4 Neurologic, Breast, and Neuroendocrine PET Agents
8 Therapeutics, Adjuncts & Administration
8.1 Therapeutic Radiopharmaceuticals 8.2 Interventional and Adjunct Pharmaceuticals 8.3 Blood Labeling and Administration Techniques 8.4 Blockade, Comfort, and Gastrointestinal Adjunct Agents
9 Non-Imaging Instrumentation
9.1 Well Counters, Probes, and Survey Meters 9.2 Dose Calibrator Quality Control 9.3 Auxiliary and Patient Care Equipment
10 Imaging Systems & Quality Control
10.1 Gamma Camera Quality Control 10.2 SPECT and SPECT/CT Systems 10.3 PET and PET/CT Systems and QC 10.4 CT Systems, PACS, and Information Systems 10.5 CT Radiation Dose, Safety Alerts, and Protocol Optimization
11 Pulmonary, Bone, Oncology & Infection Imaging
11.1 Pulmonary Imaging Procedures 11.2 Bone and Musculoskeletal Imaging 11.3 Oncology Imaging Procedures 11.4 Infection Imaging Procedures
12 Renal, Endocrine & Hematopoietic Imaging
12.1 Renal and Genitourinary Imaging 12.2 Endocrine Imaging (Thyroid, Parathyroid, Adrenal) 12.3 Hematopoietic and Bone Marrow Imaging 12.4 Thyroid Uptake Measurement and Radioiodine Survey Technique
13 Cardiovascular Procedures
13.1 Myocardial Perfusion Imaging 13.2 Cardiac Function, Viability, and Special Studies 13.3 Exercise and Pharmacologic Stress Testing
14 GI, CNS, Therapy & Hybrid CT Procedures
14.1 Gastrointestinal Procedures 14.2 Central Nervous System Procedures 14.3 Radionuclide Therapy Procedures 14.4 CT and Hybrid Imaging in Nuclear Medicine 14.5 CSF Studies: Cisternography, Leak Localization, and Shunt Patency
15 Patient Care & Clinical Workflow
15.1 Patient Care, Education, and Consent 15.2 Scheduling and Radiopharmaceutical Procurement 15.3 Acquisition, Positioning, and Image Quality 15.4 Image Processing and Quantitative Analysis 15.5 Non-Imaging Studies: Specimens, Counting, and Error Analysis
15.1 Patient Care, Education, and Consent
Key Takeaways Explain This Topic AI
HIPAA requires minimum necessary use/disclosure of PHI; nuclear medicine technologists protect identity, images, reports, and spoken details in public areas, elevators, and waiting rooms.
Verify identity with at least two identifiers (armband + verbal name/DOB ± barcode scan) before every radiopharmaceutical administration, and reconcile the written/electronic order with the scheduled study and dose.
Pre-exam screening covers prep compliance, pregnancy/breastfeeding, contraindications, history, medications, allergies, recent contrast/procedures, and labs (e.g., creatinine before CT contrast; TSH/pregnancy when protocol requires).
Informed consent may be written or verbal per procedure risk and institutional policy; technologists educate on what happens, radiation precautions, activity restrictions, and therapy/inpatient release criteria—not medical diagnosis.
Emergency readiness includes recognizing syncope, seizure, and code responses; post-procedure assessment and correct biohazard disposal (sharps, blood, contaminated waste) close the care loop.
Last updated: August 2026
15.1 Patient Care, Education, and Consent
Quick Answer: Protect PHI (HIPAA) , confirm two patient identifiers , screen prep/contraindications/history/meds/allergies/labs , obtain or confirm informed consent , educate on procedure + precautions + release , and be ready for syncope, seizure, or code . Transfer safely, manage support devices (e.g., Foley), assess after the study, and dispose of biohazard/sharps correctly.
Clinical Procedures (Domain V) treats every study as a patient-care episode . CNMT items test the full sequence—from greeting through release—not only collimator choice.
HIPAA Privacy in the Nuclear Medicine Suite
The Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule governs protected health information ( PHI ): names, medical record numbers, dates of birth, images, reports, appointment lists, and verbal details that can identify a patient.
- Practice Why it matters
- Discuss cases only with need-to-know staff Minimum necessary standard
- Avoid hallway/elevator/waiting-room clinical talk Incidental disclosure risk
- Log off workstations; face monitors away from public view Screen privacy
- Release images/results only through authorized channels Patient rights + institutional policy
- Shred or secure printed schedules with PHI Paper is still PHI
Nuclear medicine adds unique PHI vectors: hot-lab dose logs , camera worklists , and therapy written directives . Do not photograph identifiers on personal devices; de-identify teaching cases per policy.
Basic Patient Care: Vitals, First Aid, Infection Control
Technologists obtain or document vital signs when ordered or protocol-required (e.g., pharmacologic stress, therapy observation, unstable patients). Flag emergencies such as sudden hypotension after upright transfer, chest-pain tachycardia, or desaturation.
First aid / emergency recognition at the tech level:
Situation Immediate tech actions (high-level)
Fainting (syncope) Support patient to floor safely, protect head, elevate legs if appropriate, call for help, check responsiveness/breathing
Seizure Protect from injury, time the event, do not force objects into the mouth, recovery position when safe, activate emergency response
Code / unresponsiveness Call code team, begin BLS per training/certification, retrieve crash cart/AED, clear space for responders
Infection control: hand hygiene; standard precautions for all patients; transmission-based precautions as posted; disinfect camera surfaces, pads, and positioning aids between patients. Blood-borne pathogen spills follow institutional BBP procedures— not identical to a radioactive spill workflow (both may apply after a therapy accident).
Transfer Techniques and Support Devices
Safe transfer prevents falls and line disconnections. Assess mobility, use gait belts/slide boards when indicated, lock brakes, and never leave a fall-risk patient unattended on the table. For Foley catheters , keep the bag below bladder level , avoid kinks, and never rest it on the abdomen or detector. Keep IVs, oxygen, chest tubes, and drains patent during table motion—coordinate with nursing before disconnecting.
Patient Identification, Orders, and Pre-Exam Screening
Identification uses at least two identifiers —commonly armband name/MRN plus verbal full name and date of birth, often with barcode scan . Verify identity immediately before radiopharmaceutical administration, not only at check-in hours earlier.
Orders: confirm the electronic/written order matches the scheduled procedure, laterality/site when relevant, and authorized prescribing clinician. Question incomplete, conflicting, or outdated orders before drawing or administering activity.
Pre-exam screening checklist (exam favorites):
- Screen item Examples / why
- Prep compliance NPO, low-iodine diet, bowel prep, hydration, voiding
Contraindications Pregnancy for many studies; specific agent allergies; inability to lie flat for long SPECT when no alternative
- History Prior NM studies, surgery, known disease, claustrophobia
- Medications Interfering drugs (e.g., for MIBG, thyroid, cardiac stress protocols)
- Allergies Contrast, latex, medications used as adjuncts
Labs / special status Creatinine/eGFR before IV CT contrast; pregnancy test; TSH status for thyroid cancer pathways
Recent procedures Iodinated contrast, barium, other tracers still on board
Document positive findings and escalate to the authorized user/physician when the study should be delayed, modified, or cancelled.
Informed Consent: Written vs Verbal
Informed consent means the patient (or legal surrogate) understands the procedure, material risks/benefits/alternatives at an appropriate level, and agrees voluntarily. Low-risk diagnostic exams often use verbal consent plus education; invasive procedures, research, and many therapeutic administrations require written consent (therapy also ties to written directives ).
Technologists confirm consent, answer logistics questions, and stop if consent is revoked or capacity is unclear—never pressure patients. Use plain language.
Education, Precautions, Restrictions, and Release Criteria
Teach what will happen (injection, wait, scan length, breath-holds), radiation precautions when applicable (hydration/voiding for bladder dose reduction; time/distance/hygiene after therapy), activity restrictions (driving after sedation, close contact with infants after high-activity therapy), and when to seek care (infiltrate symptoms, allergic reaction).
- Setting Education focus
- Outpatient diagnostic Timing, NPO if needed, post-void imaging, usual daily activity unless instructed
- Inpatient Coordinate transport, lines, isolation status, nursing handoff of residual activity/precautions
- Travel Airport/monitor letters for residual activity when policy provides them
Therapy (e.g., I-131) Home isolation rules, toilet hygiene, laundry, duration of restrictions, release criteria based on dose rate/activity rules
Release criteria after therapy follow NRC/agreement-state rules—technologists measure dose rates and document teaching, but the authorized user owns medical release decisions.
Post-Procedure Assessment and Biohazard Disposal
After imaging or therapy, reassess comfort, access sites, vitals when indicated, and ambulation. Report complications promptly. Dispose of sharps in puncture-resistant containers; bag blood-contaminated materials as biohazard; segregate radioactive waste per half-life and license rules—never mix ordinary trash with radioactive or infectious waste.
Bottom line: privacy + two identifiers + order/screen/consent + education + emergency readiness + clean disposal define safe CNMT-level patient care.